Raleigh-based HyperBranch Medical Technology (www.hyberbranch.com) recently was selected as the Outstanding Early Stage Presentation during the 6 th annual Southeastern Bio Investor Forum (SEBIO) in Miami. HyperBranch was stood out among of group of 16 early-stage companies that were competitively selected to present at the conference.
Founded in 2003, HyperBranch is a biomaterial device company that is focused on restoring vision or preventing serious vision loss through the development of new medical devices for ocular surgery. The company’s initial products, an Endocapsular Lens (DendriLens) for presbyopic and cataract surgery and an Ocular Sealant (OcuSeal) for ocular surgical procedures are in development. SEBIO was
HyperBranch’s first investor conference.
HyperBranch is a CED Member.